首页 | 本学科首页   官方微博 | 高级检索  
     


Multicenter,randomized, placebo‐controlled,double‐blind clinical trial of escitalopram on the progression‐delaying effects in Alzheimer's disease
Authors:Young Min Choe  Ki Woong Kim  Jin Hyeong Jhoo  Seung Ho Ryu  Eun Hyun Seo  Bo Kyung Sohn  Min Soo Byun  Jae‐Hwa Bak  Jong‐Min Lee  Hyuk Jin Yun  Myeong‐il Han  Jong Inn Woo  Dong Young Lee
Affiliation:1. Department of Neuropsychiatry, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea;2. Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Korea;3. Department of Neuropsychiatry, Kangwon National University Hospital, Chunchon, Korea;4. Department of Neuropsychiatry, Konkuk University Hospital, Seoul, Korea;5. Division of Natural Medical Sciences, College of Health Science Chosun University, Gwangju, Korea;6. Department of Neuropsychiatry, SMG‐SNU Boramae Medical Center, Seoul, Korea;7. Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Korea;8. Department of Biomedical Engineering, Hanyang University, Seoul, Korea;9. Department of Psychiatry, Maeumsarang Hospital, Wanju, Korea
Abstract:
Keywords:clinical trial  escitalopram  selective serotonin reuptake inhibitor  magnetic resonance imaging  brain atrophy  Alzheimer's disease
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号